UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Prescription opioid use before and after kidney transplant: Implications for posttransplant outcomes

American journal of transplantation, 2018-12, Vol.18 (12), p.2987-2999

2018

Volltextzugriff (PDF)

The impact of direct‐acting antiviral agents on liver and kidney transplant costs and outcomes

American journal of transplantation, 2018-10, Vol.18 (10), p.2473-2482

2018

Volltextzugriff (PDF)

Sirolimus Use and Cancer Incidence Among US Kidney Transplant Recipients

American journal of transplantation, 2015-01, Vol.15 (1), p.129-136

2015

Volltextzugriff (PDF)

Measuring Council Health to Transform Shared Governance Processes and Practice

The Journal of nursing administration, 2020-02, Vol.50 (2), p.104-108

2020

Volltextzugriff (PDF)

Metformin use in the first year after kidney transplant, correlates, and associated outcomes in diabetic transplant recipients: A retrospective analysis of integrated registry and pharmacy claims data

Clinical transplantation, 2018-08, Vol.32 (8), p.e13302-n/a

2018

Volltextzugriff (PDF)

The reliability and validity of a brief diabetes knowledge test

Diabetes care, 1998-05, Vol.21 (5), p.706-710

1998

Volltextzugriff (PDF)

Residual abdominal lymphadenopathy after intensive frontline chemoimmunotherapy is associated with inferior outcome independently of minimal residual disease status in chronic lymphocytic leukemia

Leukemia, 2020-03, Vol.34 (3), p.924-928

2020

Volltextzugriff (PDF)

Spironolactone diminishes urinary albumin excretion in patients with type 1 diabetes and microalbuminuria: a randomized placebo-controlled crossover study

Diabetic medicine, 2012-08, Vol.29 (8), p.e184-e190

2012

Volltextzugriff (PDF)

Predonation Prescription Opioid Use: A Novel Risk Factor for Readmission After Living Kidney Donation

American journal of transplantation, 2017-03, Vol.17 (3), p.744-753

2017

Volltextzugriff (PDF)

The addition of rituximab to front-line therapy with CHOP (R-CHOP) results in a higher response rate and longer time to treatment failure in patients with lymphoplasmacytic lymphoma: results of a randomized trial of the German Low-Grade Lymphoma Study Group (GLSG)

Leukemia, 2009-01, Vol.23 (1), p.153-161

2009

Volltextzugriff (PDF)

Professional nursing governance in a large Australian health service

Contemporary nurse : a journal for the Australian nursing profession, 2012-12, Vol.43 (1), p.99-106

2012

Volltextzugriff (PDF)

Bortezomib Retreatment in Relapsed Multiple Myeloma – Results from a Retrospective Multicentre Survey in Germany and Switzerland

Oncology, 2010-01, Vol.79 (3-4), p.247-254

2010

Volltextzugriff (PDF)

Current treatment of mantle cell lymphoma: results of a national survey and consensus meeting

Annals of hematology, 2012-11, Vol.91 (11), p.1765-1772

2012

Volltextzugriff (PDF)

Induction of psychogenic nonepileptic seizures without placebo

Neurology, 2000-12, Vol.55 (12), p.1904-1905

2000

Volltextzugriff (PDF)

Detection of the Hepatitis G Virus Genome among Injecting Drug Users, Homosexual and Bisexual Men, and Blood Donors

The Journal of infectious diseases, 1996-12, Vol.174 (6), p.1320-1323

1996

Volltextzugriff (PDF)

Ibrutinib combined with immunochemotherapy with or without autologous stem-cell transplantation versus immunochemotherapy and autologous stem-cell transplantation in previously untreated patients with mantle cell lymphoma (TRIANGLE): a three-arm, randomised, open-label, phase 3 superiority trial of the European Mantle Cell Lymphoma Network

The Lancet (British edition), 2024-05, Vol.403 (10441), p.2293-2306

2024

Volltextzugriff (PDF)

Measuring Nursing Governance

Nursing research (New York), 1998-01, Vol.47 (1), p.35-42

Hess, Robert G

1998

Volltextzugriff (PDF)

Prognosis of patients with primary central nervous system lymphoma after high-dose chemotherapy followed by autologous stem cell transplantation

Haematologica (Roma), 2013-05, Vol.98 (5), p.765-770

2013

Volltextzugriff (PDF)

Safety and feasibility of CHOP rituximab induction treatment followed by high-dose chemo radiotherapy and autologous PBSC-transplantation in patients with previously untreated mantle cell or indolent B-cell-non-Hodgkin's lymphoma

Bone marrow transplantation (Basingstoke), 2003-05, Vol.31 (9), p.775-782

2003

Volltextzugriff (PDF)

Community diabetes care. A 10-year perspective

Diabetes care, 1994-10, Vol.17 (10), p.1124-1134

1994

Volltextzugriff (PDF)

Rituximab in vivo purging is safe and effective in combination with CD34-positive selected autologous stem cell transplantation for salvage therapy in B-NHL

Bone marrow transplantation (Basingstoke), 2002-05, Vol.29 (9), p.769-775

2002

Volltextzugriff (PDF)

Safety and efficacy of STI-571 (imatinib mesylate) in patients with bcr/abl-positive chronic myelogenous leukemia (CML) after autologous peripheral blood stem cell transplantation (PBSCT)

Leukemia, 2002-07, Vol.16 (7), p.1220-1228

2002

Volltextzugriff (PDF)

1 – 25 von 701

Suche als RSS-Feed

Aktive Filter

ThemaAdult

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(610)
Mit Volltextzugriff
(527)

Publikationsform

Artikel
(701)

Sprache

2 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

The Journal Of Trauma
(16)
Blood
(15)
Circulation
(14)
Journal Of The American College Of Cardiology
(14)
The New England Journal Of Medicine
(11)
Annals Of Oncology
(9)
Cancer
(9)
Hno
(9)
Journal Of Clinical Oncology
(9)
Journal Of Medical Virology
(9)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trial

Prescription opioid use before and after kidney transplant: Implications for posttransplant outcomes

The impact of direct‐acting antiviral agents on liver and kidney transplant costs and outcomes

Sirolimus Use and Cancer Incidence Among US Kidney Transplant Recipients

Measuring Council Health to Transform Shared Governance Processes and Practice

Allogeneic transplantation in multiple myeloma: long-term follow-up and cytogenetic subgroup analysis

Metformin use in the first year after kidney transplant, correlates, and associated outcomes in diabetic transplant recipients: A retrospective analysis of integrated registry and pharmacy claims data

The reliability and validity of a brief diabetes knowledge test

Residual abdominal lymphadenopathy after intensive frontline chemoimmunotherapy is associated with inferior outcome independently of minimal residual disease status in chronic lymphocytic leukemia

Spironolactone diminishes urinary albumin excretion in patients with type 1 diabetes and microalbuminuria: a randomized placebo-controlled crossover study

Predonation Prescription Opioid Use: A Novel Risk Factor for Readmission After Living Kidney Donation

The addition of rituximab to front-line therapy with CHOP (R-CHOP) results in a higher response rate and longer time to treatment failure in patients with lymphoplasmacytic lymphoma: results of a randomized trial of the German Low-Grade Lymphoma Study Group (GLSG)

Professional nursing governance in a large Australian health service

Bortezomib Retreatment in Relapsed Multiple Myeloma – Results from a Retrospective Multicentre Survey in Germany and Switzerland

Current treatment of mantle cell lymphoma: results of a national survey and consensus meeting

Induction of psychogenic nonepileptic seizures without placebo

Detection of the Hepatitis G Virus Genome among Injecting Drug Users, Homosexual and Bisexual Men, and Blood Donors

Outcomes of younger patients with mantle cell lymphoma experiencing late relapse (>24 months): the LATE-POD study

Measuring Nursing Governance

Prognosis of patients with primary central nervous system lymphoma after high-dose chemotherapy followed by autologous stem cell transplantation

Safety and feasibility of CHOP rituximab induction treatment followed by high-dose chemo radiotherapy and autologous PBSC-transplantation in patients with previously untreated mantle cell or indolent B-cell-non-Hodgkin's lymphoma

Community diabetes care. A 10-year perspective

Rituximab in vivo purging is safe and effective in combination with CD34-positive selected autologous stem cell transplantation for salvage therapy in B-NHL

Safety and efficacy of STI-571 (imatinib mesylate) in patients with bcr/abl-positive chronic myelogenous leukemia (CML) after autologous peripheral blood stem cell transplantation (PBSCT)

Aktive Filter

Suchergebnisse filtern